Synthesis inhibition refers to the process of blocking the production of specific biological molecules within the body. This can be achieved using pharmaceutical agents, genetic interventions, or dietary modifications. In the context of neonatal disorders, synthesis inhibition aims to prevent the accumulation of toxic substances or correct metabolic imbalances that could harm the infant's development and health.
